Effective drug combinations in breast, colon and pancreatic cancer cells
2022 · Nature · 440 citations
https://doi.org/10.1038/s41586-022-04437-2
P
Patricia Jaaks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
2.0K
Citations
18
h-index
22
i10-index
Patricia Jaaks is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Computational Drug Discovery Methods & Melanoma and MAPK Pathways & Cytokine Signaling Pathways and Interactions. The author has an h-index of 18, co-authored 125 publications.
ORCID: 0000-0002-0041-4313Papers by this author
worksTargeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma
2015 · Oncogene · 53 citations
https://doi.org/10.1038/onc.2015.267
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
2022 · Oncogene · 30 citations
https://doi.org/10.1038/s41388-022-02482-9
Validation_screen_All_tissues_raw_data.csv.zip
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19141922
Validation_screen_All_tissues_day1_data.csv.zip
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19141928
Original_screen_All_tissues_day1_data.csv.zip
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19141919
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat